Skip to main content
. 2011 Nov 9;2:68. doi: 10.3389/fendo.2011.00068

Figure 1.

Figure 1

G-protein-dependent pathways either used endogenously by GPR35 (G12/13, Gi/o) or subverted (Gq/11) to allow screening of potential agonists of GPR35 via chimeric and/or promiscuous G-proteins.